Blog
Blog
Video
Blog
19 May, 2021 Author Morgan Frey
The pandemic-fueled popularity of online tools for primary and chronic care have emboldened investors to seek more specialized opportunities in digital health. Women s health may be their next target.
With patients pushed online by COVID-19, companies like Teladoc Health Inc. whose share price more than doubled in 2020 got a warm reception on Wall Street. That led to greater interest in digital tools aimed at treating a chronic care population with conditions like diabetes and heart disease.
The enthusiasm has not quite caught up with digital women s health, often dubbed femtech. The field includes companies focused on maternal care, fertility and gynecologic care and is expanding into areas such as menopausal care and female reproductive cancers.